GC Therapeutics: Funding, Investors & Team (Oct 2026)
GC Therapeutics utilizes synthetic biology to efficiently and effectively program patient-derived stem cells into different types of cells. They have successfully engineered cells for multiple uses in a single process and have also developed specialized cells called SuperCells™ tailored to specific conditions. The foundational technology for GC Therapeutics was created and perfected in Professor George Church's lab at Harvard Medical School. The team at GC Therapeutics, made up of committed biologists and tissue engineers, aims to make this innovative approach accessible to patients.
GC Therapeutics has raised $65.0M across 1 funding round on record, the most recent a Series A of $65.0M announced in Sep 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
GC Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
GC Therapeutics Funding Rounds
GC Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
GC Therapeutics Funding Compared to Other Biotechnology Startups
GC Therapeutics' latest round of $65.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GC Therapeutics in Biotechnology and Boston
Companies Similar to GC Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
GC Therapeutics Funding FAQs
What does GC Therapeutics do?
GC Therapeutics utilizes synthetic biology to efficiently and effectively program patient-derived stem cells into different types of cells. They have successfully engineered cells for multiple uses in a single process and have also developed specialized cells called SuperCells™ tailored to specific conditions. The foundational technology for GC Therapeutics was created and perfected in Professor George Church's lab at Harvard Medical School. The team at GC Therapeutics, made up of committed biologists and tissue engineers, aims to make this innovative approach accessible to patients.
How much funding has GC Therapeutics raised?
GC Therapeutics has raised $65.0M across 1 round on record. The most recent is a Series A of $65.0M announced in Sep 2024.
When did GC Therapeutics last raise funding?
GC Therapeutics' most recent funding round on record is a Series A of $65.0M, announced in Sep 2024.
Who founded GC Therapeutics?
FundedIQ lists Parastoo Khoshakhlagh (Founder) at GC Therapeutics.
Where is GC Therapeutics headquartered?
GC Therapeutics is based in Boston, Massachusetts, United States.
How many employees does GC Therapeutics have?
GC Therapeutics is in the 11-50 employee band.
How does GC Therapeutics' funding compare to other Biotechnology startups?
GC Therapeutics' latest round of $65.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's GC Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GC Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.